Your browser doesn't support javascript.
loading
Evaluation of the acceptability in France of the vaccine against papillomavirus (HPV) among middle and high school students and their parents.
Huon, Jean-François; Grégoire, Antoine; Meireles, Anita; Lefebvre, Maëva; Péré, Morgane; Coutherut, Julie; Biron, Charlotte; Raffi, François; Briend-Godet, Valérie.
Afiliação
  • Huon JF; Clinical Pharmacy of the UHC of Nantes, and UMR INSERM 1246 SPHERE Universities of Nantes and Tours, Nantes, France.
  • Grégoire A; Center for the Prevention of Infectious and Transmitted Diseases of the UHC of Nantes, Nantes, France.
  • Meireles A; Center for the Prevention of Infectious and Transmitted Diseases of the UHC of Nantes, Nantes, France.
  • Lefebvre M; Center for the Prevention of Infectious and Transmitted Diseases of the UHC of Nantes, Nantes, France.
  • Péré M; Department of Infectious Diseases, and CIC 1413, INSERM, University Hospital Center of Nantes, Nantes, France.
  • Coutherut J; Plateforme de Méthodologie et Biostatistique, Direction de la Recherche, CHU de Nantes, Nantes, France.
  • Biron C; Center for the Prevention of Infectious and Transmitted Diseases of the UHC of Nantes, Nantes, France.
  • Raffi F; Center for the Prevention of Infectious and Transmitted Diseases of the UHC of Nantes, Nantes, France.
  • Briend-Godet V; Department of Infectious Diseases, and CIC 1413, INSERM, University Hospital Center of Nantes, Nantes, France.
PLoS One ; 15(10): e0234693, 2020.
Article em En | MEDLINE | ID: mdl-33091021
BACKGROUND: The pathogenic and oncogenic roles of papillomavirus (HPV) infections have been documented and shown to occur in women as well as in men. While other countries have already extended their vaccination guidelines to include boys, in 2019 the French National Authority for Health validated implementation of HPV vaccination in the 2020 vaccination schedule. There is, however, a climate of distrust in regard to vaccination in France, and there have been few studies to date regarding the acceptability of HPV vaccination in boys in France. The aim of this study was, therefore, to evaluate the acceptability of extending the recommendations for HPV vaccination in men, among middle and high school students and their parents. METHODS: Our study (HPVac) was a prospective, multicenter, departmental, and descriptive survey applied to a sample of male middle and high school students attending schools in the Loire-Atlantique department and their parents. It took place from January 2017 to January 2018. RESULTS: We analyzed the information obtained from 127 parent questionnaires and 145 children questionnaires. In terms of acceptability, 36.6% (n = 53) of the children and 37.8% (n = 48) of the parents were in favour of being vaccinated or of having their children vaccinated against HPV (51.7% (n = 75) and 50.4% (n = 64), respectively, were undecided). The perception of a risk stemming from HPV infection was positively associated with acceptability of the HPV vaccine. Being against vaccines in general, being discouraged by their parents, parents thinking that their child is not at risk, and the belief that the vaccine is not mandatory were arguments cited and significantly associated with a willingness to be vaccinated. CONCLUSION: This study revealed a lack of information among boys and their parents about HPV and its vaccination. It also clearly showed that taking time to discuss the consequences of an infection and the merits of being vaccinated can help parents overcome their reluctance. The children then generally go along with their parent's choice.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Papillomaviridae / Pais / Estudantes / Aceitação pelo Paciente de Cuidados de Saúde / Vacinação / Infecções por Papillomavirus / Vacinas contra Papillomavirus Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Papillomaviridae / Pais / Estudantes / Aceitação pelo Paciente de Cuidados de Saúde / Vacinação / Infecções por Papillomavirus / Vacinas contra Papillomavirus Idioma: En Ano de publicação: 2020 Tipo de documento: Article